| 摘要 |
<p>Methods are provided for lowering plasma level of HbAIc in a diabetic, pre- diabetic, or non-diabetic patient suffering from at least one cardiovascular disease and slowing or delaying the development of or worsening of hyperglycemia in a diabetic, pre-diabetic, or non-diabetic patient.</p> |
